<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Numerous <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> therapeutics were originally identified from <z:chebi fb="15" ids="33243">natural products</z:chebi> used in traditional medicine </plain></SENT>
<SENT sid="1" pm="."><plain>One such agent is <z:chebi fb="9" ids="46887">acetyl</z:chebi>-11-keto-beta-boswellic acid (AKBA), derived from the gum resin of the Boswellia serrata known as Salai guggal or Indian frankincense </plain></SENT>
<SENT sid="2" pm="."><plain>Traditionally, it has been used in Ayurvedic medicine to treat proinflammatory conditions </plain></SENT>
<SENT sid="3" pm="."><plain>In this report, we hypothesized that AKBA can affect the growth and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) in orthotopically implanted <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in <z:mp ids='MP_0003815'>nude</z:mp> mice </plain></SENT>
<SENT sid="4" pm="."><plain>We found that the oral administration of AKBA (50-200 mg/kg) dose-dependently inhibited the growth of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in mice, resulting in decrease in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> volumes than those seen in vehicle-treated mice without significant decreases in body weight </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, we observed that AKBA was highly effective in suppressing <z:hpo ids='HP_0001541'>ascites</z:hpo> and distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> to the liver, lungs and spleen in orthotopically implanted <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in <z:mp ids='MP_0003815'>nude</z:mp> mice </plain></SENT>
<SENT sid="6" pm="."><plain>When examined for the mechanism, we found that markers of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> proliferation index Ki-67 and the microvessel density cluster of differentiation (CD31) were significantly downregulated by AKBA treatment </plain></SENT>
<SENT sid="7" pm="."><plain>We also found that AKBA significantly suppressed nuclear factor-κB (NF-κB) activation in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue and expression of proinflammatory (cyclooxygenase-2), <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> survival (bcl-2, bcl-xL, inhibitor of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> (IAP-1) and survivin), proliferative (cyclin D1), invasive (intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule 1 and matrix metalloproteinase-9) and angiogenic C-X-C (CXC) receptor 4 and vascular endothelial growth factor) biomarkers </plain></SENT>
<SENT sid="8" pm="."><plain>When examined for serum and tissue levels of AKBA, a dose-dependent increase in the levels of the drug was detected, indicating its bioavailability </plain></SENT>
<SENT sid="9" pm="."><plain>Thus, our findings suggest that this boswellic acid analog can inhibit the growth and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in vivo through downregulation of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-associated biomarkers </plain></SENT>
</text></document>